Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease

Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or COPD in Iceland

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01369810

Enrollment

20000

Registered

2011-06-09

Start date

2011-07-31

Completion date

2013-09-30

Last updated

2013-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Chronic Obstructive Pulmonary Disease

Keywords

Epidemiological, asthma, COPD, reimbursement, switch, outcomes associated with the change in reimbursement

Brief summary

To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All patients who was on treatment with fixed combination asthma or COPD therapy by January 1 2010

Design outcomes

Primary

Measure	Time frame
To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure	Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years

Secondary

Measure	Time frame
To map out the development of asthma and COPD treatment in Iceland after the change in reimbursement	Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years
To investigate health economic outcomes	Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years

Countries

Sweden

Outcome results